Home 2018-01-08T21:57:06+00:00

The new science of accelerating innovation

Omics + big data + biomarker-guided drug development. It’s a new reality, bringing unprecedented abilities to interrogate and translate biological information—and unprecedented opportunities for life sciences companies to achieve their goals faster and more cost-effectively. This fundamental shift requires a new approach to drug development. Precision for Medicine is leading the way.

Explore our services
« Back

Precision for Medicine can help you find and extract the long-term value of innovative drugs

We develop your assays and manage global logistics, speeding to actionable answers. We use biomarkers to stratify patients, incomparably improving your R&D efficiency and success. We manage every aspect of your clinical trials from sites to biomarkers to diagnostics, all under a single roof. In short: we dramatically accelerate your pathway from proof of concept to drug approval.

News & Insights
  • Precision’s Clark and Marshall Advocate for Biomarker Data Management in Bioscience Technology Online

  • Precision's Messerschmidt Talks Immunotherapy with ASCO Post

  • Briefing: Best Practices for the Expedited Start-Up of Oncology Trials

    Precision subject matter expert, Tandy Tipps, highlights how oncology sites can...

Thought Leadership
  • Choosing the Right Partner: Special Sample Needs For In Vitro Diagnostics

  • Barriers to Progress: Why Personalized Medicine Hasn't Developed for Chronic Conditions

  • 6 Critical Factors for Achieving Approval of Oncology Drugs

    In this high-stakes, high-velocity environment of oncology drug development and...


Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.